Furthermore, our observation that increased serum IL-8and GRO-α were absent in MS patients, but present in 60% of AQP4-Ab positivepatients and 63% of MOG-Ab positive patients might be helpful to establish noveldiagnostic biomarkers for these syndromes. This evidence concerns the gene MOG and myeloid sarcoma.